IP Library Granted Patent US 12,280,128
Granted Patent B2
US 12,280,128 · App. 17/682,740 · Granted Apr 22, 2025

Multi-phase oral composition

Inventors: Jayanth Rajaiah (Loveland, OH); Paul Albert Sagel (Mainville, OH); Franco Silva Medeiros (Loveland, OH)
Assignee: The Procter & Gamble Company
A61K8/064A61C19/066A61K8/0216A61K8/062A61K8/22A61K8/31A61K8/345A61K8/8111A61K8/86A61K8/92A61N5/0603A61N5/062A61Q11/00A61Q11/02A61K2800/42A61K2800/81A61K2800/87A61K2800/884A61K2800/92A61N2005/0606A61N2005/0663
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,280,128
App. No.
17/682,740
Granted
Apr 22, 2025
Kind
B2
Abstract

A multi-phase oral composition for whitening teeth.

Claims (26)

1. A multi-phase oral composition comprising:

a) from about 0.9% to about 40%, by weight of the multi-phase oral composition, of an aqueous phase having a bleaching agent, wherein the amount of the bleaching agent in the multi-phase oral composition is from more than 0.5% to about 20%;

b) a hydrophobic phase comprising from about 50% to about 99.1%, by weight of the multi-phase oral composition, of petrolatum having a drop melting point from about 30° C. to about 90° C. as measured by ASTM D127-08.

2. The multi-phase oral composition according to claim 1 , wherein a cone penetration consistency value of the hydrophobic phase is from about 50 to about 300, as measured by ASTM D937-07.

3. The multi-phase oral composition according to claim 2 , wherein the cone penetration consistency value of the hydrophobic phase is from about 100 to about 250, as measured by ASTM D937-07.

4. The multi-phase oral composition according to claim 1 , wherein the drop melting point of the hydrophobic phase is from about 40° C. to about 80° C., as measured by ASTM D127-08.

5. The multi-phase oral composition according to claim 4 , wherein the drop melting point of the hydrophobic phase is from about 50° C. to about 80° C., as measured by ASTM D127-08.

6. The multi-phase oral composition according to claim 1 , wherein a two-dimensional density of droplets with a cross-sectional area larger than about 10000 square microns measured using the procedure specified herein is no more than about 20 per square centimeter.

7. The multi-phase oral composition according to claim 6 , wherein the two-dimensional density of droplets with a cross-sectional area larger than about 10000 square microns measured using the procedure specified herein is no more than about 10 per square centimeter.

8. The multi-phase oral composition according to claim 1 , wherein a standard deviation of a peroxide intensity of the multi-phase oral composition smeared onto peroxide test strips measured using the procedure specified herein is no more than about 50.

9. The multi-phase oral composition according to claim 8 , wherein the standard deviation of the peroxide intensity of the multi-phase oral composition smeared onto peroxide test strips measured using the procedure specified herein is no more than about 25.

10. The multi-phase oral composition according to claim 1 , wherein a mean peroxide intensity of the multi-phase oral composition smeared onto peroxide test strips measured using the procedure specified herein is from about 1 to about 100.

11. The multi-phase oral composition according to claim 1 , wherein a mean residual peroxide intensity of the multi-phase oral composition smeared on teeth measured using the procedure specified herein is from about 20 to about 200.

12. The multi-phase oral composition according to claim 11 , wherein the bleaching agent comprises hydrogen peroxide.

13. The multi-phase oral composition according to claim 1 , wherein the hydrophobic phase further comprises mineral oil thickened with wax, mineral oil thickened with polyethylene, or a combination thereof.

14. The multi-phase oral composition according to claim 1 , wherein a bleaching efficacy of the multi-phase oral composition calculated as −Δb* and measured per the clinical protocol as disclosed herein is at least about 1.5.

15. The multi-phase oral composition according to claim 1 , wherein a ratio of a bleaching efficacy of the multi-phase oral composition calculated as −Δb* and measured per the clinical protocol as disclosed herein to a weight percentage of bleaching agent present in the overall multi-phase oral composition is at least about 1.5.

16. The multi-phase oral composition according to claim 1 comprising a delivery carrier.

17. The multi-phase oral composition according to claim 16 , wherein the delivery carrier is a strip.

18. A method for whitening teeth comprising using the multi-phase oral composition according to claim 16 comprising:

a) applying the multi-phase oral composition to the delivery carrier;

b) applying the delivery carrier to at least one tooth surface, such that the delivery carrier contacts the multi-phase oral care composition against the at least one tooth surface.

19. A kit for whitening teeth comprising:

a) the multi-phase oral composition of claim 16 ; and

b) an electromagnetic radiation source capable of directing electromagnetic radiation with one or more wavelengths in the range from about 200 nm to about 1700 nm towards at least one tooth.

20. The kit for whitening teeth according to claim 19 , wherein the electromagnetic radiation source emits electromagnetic radiation in the range from about 400 nm to about 500 nm, impinging on the outer surface of the delivery carrier in the range from about 175 mW/cm2 to about 225 mW/cm2 measured using the procedures described herein.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2022
From: RAJAIAH, JAYANTH (NMN); SAGEL, PAUL ALBERT; MEDEIROS, FRANCO SILVA
To: THE PROCTER & GAMBLE COMPANY
Reel/Frame 059140/0537 →
Continuity (9)
Continuation 15790978 · Oct 23, 2017
Provisional Application 62413214 · Oct 26, 2016
Provisional Application 62413237 · Oct 26, 2016
Provisional Application 62413200 · Oct 26, 2016
Provisional Application 62413205 · Oct 26, 2016
Provisional Application 62413189 · Oct 26, 2016
Provisional Application 62413229 · Oct 26, 2016
Provisional Application 62413222 · Oct 26, 2016
Related Publication 20220175633A1 · Jun 9, 2022
References Cited (117)
US 2798053A · Brown · 1957 [cited by applicant]
US 2835628A · Saffir · 1958 [cited by applicant]
US 3506720A · Model et al. · 1970 [cited by applicant]
US 3959458A · Agricola et al. · 1976 [cited by applicant]
US 3988433A · Benedict · 1976 [cited by applicant]
US 4013770A · Bharucha · 1977 [cited by applicant]
US 4051234A · Gieske et al. · 1977 [cited by applicant]
US 5016784A · Batson · 1991 [cited by applicant]
US 5024701A · Desmarais · 1991 [cited by examiner]
US 5484542A · Cahoon · 1996 [cited by applicant]
US 5512278A · Mundschenk · 1996 [cited by applicant]
US 5766011A · Sibner · 1998 [cited by applicant]
US 5879691A · Sagel et al. · 1999 [cited by applicant]
US 5891453A · Sagel et al. · 1999 [cited by applicant]
US 5894017A · Sagel et al. · 1999 [cited by applicant]
US 5989569A · Dirksing et al. · 1999 [cited by applicant]
US 6040160A · Kojima et al. · 2000 [cited by applicant]
US 6045811A · Dirksing et al. · 2000 [cited by applicant]
US 6096328A · Sagel et al. · 2000 [cited by applicant]
US 6136297A · Sagel et al. · 2000 [cited by applicant]
US 6509007B2 · Rajaiah · 2003 [cited by applicant]
US 7025950B2 · Majeti · 2006 [cited by applicant]
US 8540971B2 · Zaidel et al. · 2013 [cited by applicant]
US 8623388B2 · Rajaiah · 2014 [cited by applicant]
US 8945519B2 · Sharma · 2015 [cited by applicant]
US 9138387B2 · Shiba · 2015 [cited by applicant]
US 10688026B2 · Latta · 2020 [cited by applicant]
US 11259998B2 · Rajaiah et al. · 2022 [cited by applicant]
US 20020006388A1 · Sagel et al. · 2002 [cited by applicant]
US 20020176827A1 · Rajaiah et al. · 2002 [cited by applicant]
US 20030072722A1 · Nathoo · 2003 [cited by examiner]
US 20030113276A1 · Rajaiah et al. · 2003 [cited by applicant]
US 20050008584A1 · Montgomery · 2005 [cited by applicant]
US 20050036958A1 · Feng · 2005 [cited by examiner]
US 20050063923A1 · Prencipe et al. · 2005 [cited by applicant]
US 20050064371A1 · Soukos · 2005 [cited by applicant]
US 20050137109A1 · Quan · 2005 [cited by examiner]
US 20050137110A1 · Scott et al. · 2005 [cited by applicant]
US 20050143274A1 · Ghosh et al. · 2005 [cited by applicant]
US 20060019214A1 · Lawrence · 2006 [cited by applicant]
US 20070054233A1 · Rizoiu et al. · 2007 [cited by applicant]
US 20070054235A1 · Rizoui et al. · 2007 [cited by applicant]
US 20070054236A1 · Rizoiu et al. · 2007 [cited by applicant]
US 20070059660A1 · Rizoiu et al. · 2007 [cited by applicant]
US 20070280894A1 · Romano · 2007 [cited by examiner]
US 20070292459A1 · Cooper · 2007 [cited by applicant]
US 20080193392A1 · Kwak et al. · 2008 [cited by applicant]
US 20080274067A1 · Chaffer · 2008 [cited by applicant]
US 20090029311A1 · Chan · 2009 [cited by applicant]
US 20090081136A1 · Sharma · 2009 [cited by applicant]
US 20090181071A1 · St. John et al. · 2009 [cited by applicant]
US 20090208543A1 · Nathoo · 2009 [cited by examiner]
US 20100196857A1 · Yarborough · 2010 [cited by applicant]
US 20110306004A1 · Sagel · 2011 [cited by applicant]
US 20120037038A1 · Rajaiah · 2012 [cited by applicant]
US 20120134936A1 · Kwak · 2012 [cited by examiner]
US 20130149262A1 · Sharma · 2013 [cited by examiner]
US 20130295525A1 · Sagel · 2013 [cited by applicant]
US 20140178443A1 · Sagel et al. · 2014 [cited by applicant]
US 20140335028A1 · Prencipe et al. · 2014 [cited by applicant]
US 20150037266A1 · Boyd et al. · 2015 [cited by applicant]
US 20150238399A1 · Spaid et al. · 2015 [cited by applicant]
US 20160074290A1 · Sagel et al. · 2016 [cited by applicant]
US 20160279039A1 · Giniger · 2016 [cited by examiner]
US 20170172864A1 · Evans · 2017 [cited by examiner]
US 20170239029A1 · Sagel · 2017 [cited by applicant]
US 20180133119A1 · Rajaiah et al. · 2018 [cited by applicant]
US 20180133120A1 · Rajaiah et al. · 2018 [cited by applicant]
US 20180133121A1 · Rajaiah et al. · 2018 [cited by applicant]
US 20180133122A1 · Rajaiah et al. · 2018 [cited by applicant]
US 20180133128A1 · Rajaiah et al. · 2018 [cited by applicant]
US 20180133502A1 · Rajaiah et al. · 2018 [cited by applicant]
US 20180140516A1 · Rajaiah et al. · 2018 [cited by applicant]
US 20180243178A1 · Nesta · 2018 [cited by examiner]
US 20180280259A1 · De Laat · 2018 [cited by examiner]
CN 1345223A · 2002 [cited by applicant]
CN 1893915A · 2007 [cited by applicant]
CN 1893917A · 2007 [cited by applicant]
CN 1933800A · 2007 [cited by applicant]
CN 101019812A · 2007 [cited by applicant]
CN 200984244Y · 2007 [cited by applicant]
CN 101663017A · 2010 [cited by applicant]
CN 102614090A · 2012 [cited by applicant]
CN 102961261A · 2013 [cited by applicant]
CN 105640787A · 2016 [cited by applicant]
DE 102007013040 · 2008 [cited by applicant]
EP 0251591 · 1988 [cited by applicant]
EP 1696866B1 · 2006 [cited by applicant]
EP 1733710 · 2006 [cited by applicant]
EP 3315119A1 · 2018 [cited by examiner]
GB 1492660A · 1977 [cited by applicant]
JP 2009126819 · 2009 [cited by applicant]
JP 2016017072 · 2014 [cited by applicant]
JP 2014152166A · 2014 [cited by applicant]
JP 2015117217 · 2015 [cited by applicant]
JP 2015528505A · 2015 [cited by applicant]
WO 03015656A2 · 2003 [cited by applicant]
WO 2005058267A1 · 2005 [cited by applicant]
WO 2006138550 · 2008 [cited by applicant]
WO 2010098761 · 2010 [cited by applicant]
WO 2013093743 · 2013 [cited by applicant]
WO WO2013093743A1 · 2013 [cited by examiner]
WO 201783570 · 2017 [cited by applicant]
PCT Search Report and Written Opinion for PCT/US2017/057872 dated Dec. 8, 2017, 11 pages. [cited by applicant]
Extended EP Search Report and Search Opinion for 21194534.0 dated Nov. 11, 2021, 7 pages. [cited by applicant]
All Office Actions; U.S. Appl. No. 15/790,978, filed Oct. 23, 2017. [cited by applicant]
Chemistry and Technology of Silicones, Walter Noll, Academic Press Inc, (Harcourt Brue Javanovich, Publishers, New York), 1968, pp. 282-287 and 409-426. [cited by applicant]
Definition of “Matrix” by Online Merriam-Webster Dictionary; Dated Jun. 3, 2020; 9 pages. [cited by applicant]
E. Dickeinson, “Emulsions and droplet size control.” Chapter 7, pp. 191-216 of book entitled: Control Particle, Droplet and Bubble Formation, Edited by David J. Bwdlock, 1994 (Year: 1994). [cited by applicant]
Encyclopedia of Polymer Science and Engineering, vol. 15, 2nd ed., pp. 204 308 Silicones, 1989. [cited by applicant]
Kirk-Othmer, Encyclopedia of Chemical Technology, Fourth Edition, vol. 21, pp. 207-218. [cited by applicant]
Kostansek, Edward, and Updated by Staff. “Emulsions.” Kirk-Othmer Encyclopedia of Chemical Technology (2000): 1-24. (Year: 2000). [cited by applicant]
Machinery Lubrication, “A Better Way to Test Grease Consistency.” www.machinerylubrication.com/Read/30271/ test-grease-consistency, Year 2015, 18 pages. [cited by applicant]
Marshall et al. “Hydrogen Peroxide: A Review of Its Use in Dentistry”, Journal of Periodontology, vol. 66, Issue 9 (Year: 1995). [cited by applicant]
Mishra, Amul, Ridhi Panola, and A. C. Rana. “Microemulsions: as drug delivery system.” J Sci Innov Res 3.4 (2014): 467-474. (Year: 2014). [cited by applicant]
Penreco, “Intelligent Gel Technology Product Specifications: Versagel M.” www.penreco.com. Jun. 2016 (Year: 2016). [cited by applicant]
Www.fao.org, “petroleum jelly-FAO”. Prepared at the 51st JECFA (1998), published in FNP 52 Add 6 (1998); 5 page. (Year: 1998). [cited by applicant]